Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022)

Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022)

Detalles Bibliográficos
Autor Principal:	Reilly, TJ
Formato:	Journal article
Idioma:	English
Publicado:	Wiley 2022

Títulos similares

NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness.
por: Tahir Hakami, et al.
Publicado: (2009-08-01)

The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.
por: Pilar eSánchez-Blázquez, et al.
Publicado: (2014-01-01)

Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction
por: David D. Aguilar, et al.
Publicado: (2021-04-01)

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
por: Kazu Nakazawa, et al.
Publicado: (2017-02-01)

NMDA Receptor Hypofunction in the Aging-Associated Malfunction of Peripheral Tissue
por: Angélica Rivera-Villaseñor, et al.
Publicado: (2021-06-01)

A circuit mechanism for decision-making biases and NMDA receptor hypofunction
por: Sean Edward Cavanagh, et al.
Publicado: (2020-09-01)

Premature commitment to uncertain decisions during human NMDA receptor hypofunction
por: Alexandre Salvador, et al.
Publicado: (2022-01-01)

Vulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction
por: Rehnuma Islam, et al.
Publicado: (2017-03-01)

Inhibition of astrocytic glycine transporter-1: friend or foe for ameliorating NMDA receptor hypofunction?
por: Philipp Singer, et al.
Publicado: (2024-05-01)

Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia
por: Colin Kehrer, et al.
Publicado: (2008-04-01)

NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
por: Wen-Jun eGao, et al.
Publicado: (2013-03-01)

Neonatal NMDA receptor blockade disrupts spike timing and glutamatergic synapses in fast spiking interneurons in a NMDA receptor hypofunction model of schizophrenia.
por: Kevin S Jones, et al.
Publicado: (2014-01-01)

Effects of NMDA Receptor Hypofunction on Inhibitory Control in a Two-Layer Neural Circuit Model
por: Weijie Ye, et al.
Publicado: (2023-09-01)

5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunction
por: Kazuhito Nakao, et al.
Publicado: (2022-04-01)

Fragile-X Syndrome Is Associated With NMDA Receptor Hypofunction and Reduced Dendritic Complexity in Mature Dentate Granule Cells
por: Suk-Yu Yau, et al.
Publicado: (2019-01-01)

Commentary on the Pinotsis and Friston Neural Fields DCM and the Cadonic and Albensi Oscillations and NMDA Receptors Articles
por: Robert A. Moss, et al.
Publicado: (2014-09-01)

Alteration of NMDA receptor trafficking as a cellular hallmark of psychosis
por: Agnès Espana, et al.
Publicado: (2021-08-01)

NMDA receptor antagonist ketamine impairs feature integration in visual perception.
por: Julia D I Meuwese, et al.
Publicado: (2013-01-01)

Ketamine Protects Gamma Oscillations by Inhibiting Hippocampal LTD.
por: Lanting Huang, et al.
Publicado: (2016-01-01)

Sex-specific effects of subchronic NMDA receptor antagonist MK-801 treatment on hippocampal gamma oscillations
por: Tim Simon Neuhäusel, et al.
Publicado: (2024-08-01)

Oscillations and NMDA Receptors: Their Interplay Create Memories
por: Chris Cadonic, et al.
Publicado: (2014-06-01)

Investigation of anti-NMDA receptor antibodies in first episode psychosis patients
por: R.I. Zsigmond, et al.
Publicado: (2022-06-01)

Anti-NMDA receptor encephalitis and psychosis: case report and literature review
por: T. Gutierrez Higueras, et al.
Publicado: (2022-06-01)

Ketamine Infusion Associated with Improved Neurology in a Patient with NMDA Receptor Encephalitis
por: Michael MacMahon, et al.
Publicado: (2013-01-01)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
por: F. A. Zeiler
Publicado: (2015-01-01)

Ketamine and rapastinel: NMDA receptor modulators in the rapid treatment of obsessive-compulsive disorder
por: Samet Kose, et al.
Publicado: (2017-07-01)

Ketamine may block NMDA receptors in astrocytescausing a rapid antidepressant effect
por: Bernhard J Mitterauer
Publicado: (2012-12-01)

Parvalbumin expression and gamma oscillation occurrence increase over time in a neurodevelopmental model of NMDA receptor dysfunction
por: Ben van Lier, et al.
Publicado: (2018-09-01)

Immune regulatory gene polymorphisms, frequent cannabis use, and psychosis: implications to Treg hypofunction
por: F. Corsi-Zuelli, et al.
Publicado: (2022-06-01)

Decision Making in Mice During an Optimized Touchscreen Spatial Working Memory Task Sensitive to Medial Prefrontal Cortex Inactivation and NMDA Receptor Hypofunction
por: Tyler D. Dexter, et al.
Publicado: (2022-05-01)

The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies
por: Marion Leboyer, et al.
Publicado: (2017-04-01)

Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors
por: Adam, Elie, et al.
Publicado: (2024)

NMDA Receptor Glycine Binding Site Modulators for Prevention and Treatment of Ketamine Use Disorder
por: Yu-Chin Hsiao, et al.
Publicado: (2023-05-01)

2-AG SIGNALING RECOVERS THE CB1 RECEPTOR-DEPENDENT LONG-TERM DEPRESSION OF THE PERFORANT PATH – GRANULE CELL SYNAPSE TRIGGERED BY NEONATAL HYPOFUNCTION OF NMDA RECEPTORS
por: Luis Márquez, et al.
Publicado: (2023-10-01)

Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task
por: Mirjana eCarli, et al.
Publicado: (2014-06-01)

The NMDA receptor antagonist ketamine impairs and delays context-dependent decision making in the parietal cortex
por: Yuki Suda, et al.
Publicado: (2022-07-01)

Introduction to AIMS Special Issue “How do Gamma Frequency Oscillations and NMDA Receptors Contribute to Normal and Dysfunctional Cognitive Performance”
por: Suresh D Muthukumaraswamy
Publicado: (2014-09-01)

Glycine attenuates impairments of stimulus-evoked gamma oscillations in the ketamine model of schizophrenia
por: Moritz Haaf, et al.
Publicado: (2022-05-01)

Anti-NMDA-receptor encephalitis presenting as postpartum psychosis in a young woman, treated with rituximab
por: Hamid Salim Shaaban, et al.
Publicado: (2012-07-01)

A critical role for NMDA receptors in parvalbumin interneurons for gamma induction and behavior
por: Jones, S. R., et al.
Publicado: (2012)